Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Anna R. Michmerhuizen"'
Autor:
Anna R. Michmerhuizen, Lynn M. Lerner, Andrea M. Pesch, Connor Ward, Rachel Schwartz, Kari Wilder-Romans, Meilan Liu, Charles Nino, Kassidy Jungles, Ruth Azaria, Alexa Jelley, Nicole Zambrana Garcia, Alexis Harold, Amanda Zhang, Bryan Wharram, Daniel F. Hayes, James M. Rae, Lori J. Pierce, Corey W. Speers
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract Endocrine therapy (ET) is an effective first-line therapy for women with estrogen receptor-positive (ER + ) breast cancers. While both ionizing radiation (RT) and ET are used for the treatment of women with ER+ breast cancer, the most effect
Externí odkaz:
https://doaj.org/article/dcd32144b036459fac1d9db7b328ac9f
Autor:
Andrea M. Pesch, Nicole H. Hirsh, Anna R. Michmerhuizen, Kassidy M. Jungles, Kari Wilder-Romans, Benjamin C. Chandler, Meilan Liu, Lynn M. Lerner, Charles A. Nino, Connor Ward, Erin F. Cobain, Theodore S. Lawrence, Lori J. Pierce, James M. Rae, Corey W. Speers
Publikováno v:
JCI Insight, Vol 7, Iss 3 (2022)
Standard radiation therapy (RT) does not reliably provide locoregional control for women with multinode-positive breast cancer and triple-negative breast cancer (TNBC). We hypothesized that CDK4/6 inhibition (CDK4/6i) would increase the radiosensitiv
Externí odkaz:
https://doaj.org/article/a01908851a6948f19c0bebb697957f52
Autor:
Anna R. Michmerhuizen, Corey Speers
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 22, Iss 10, Pp 533-535 (2020)
Externí odkaz:
https://doaj.org/article/35e77d7fe62847318a2cb82e1fd5a9dd
Autor:
Anna R. Michmerhuizen, Lynn M. Lerner, Andrea M. Pesch, Connor Ward, Rachel Schwartz, Kari Wilder-Romans, Meilan Liu, Charles Nino, Kassidy Jungles, Ruth Azaria, Alexa Jelley, Nicole Zambrana Garcia, Alexis Harold, Amanda Zhang, Bryan Wharram, Daniel F. Hayes, James M. Rae, Lori J. Pierce, Corey W. Speers
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/549150630d4b476a9dff4be90f0aa8ea
Autor:
Anna R. Michmerhuizen, Benjamin Chandler, Eric Olsen, Kari Wilder-Romans, Leah Moubadder, Meilan Liu, Andrea M. Pesch, Amanda Zhang, Cassandra Ritter, S. Tanner Ward, Alyssa Santola, Shyam Nyati, James M. Rae, Daniel Hayes, Felix Y. Feng, Daniel Spratt, Daniel Wahl, Joel Eisner, Lori J. Pierce, Corey Speers
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Increased rates of locoregional recurrence (LR) have been observed in triple negative breast cancer (TNBC) despite multimodality therapy, including radiation (RT). Recent data suggest inhibiting the androgen receptor (AR) may be an effective radiosen
Externí odkaz:
https://doaj.org/article/a54f32bc80444bdc91e0c360229a5391
Autor:
Anna R. Michmerhuizen, Lynn M. Lerner, Connor Ward, Andrea M. Pesch, Amanda Zhang, Rachel Schwartz, Kari Wilder-Romans, Joel R. Eisner, James M. Rae, Lori J. Pierce, Corey W. Speers
Publikováno v:
British Journal of Cancer. 127:927-936
Purpose Radiation therapy (RT) and hormone receptor (HR) inhibition are used for the treatment of HR-positive breast cancers; however, little is known about the interaction of the androgen receptor (AR) and estrogen receptor (ER) in response to RT in
Autor:
Corey W. Speers, James M. Rae, Lori J. Pierce, Kassidy M. Jungles, Charles A. Nino, Cassandra L. Ritter, Tanner Ward, Meilan Liu, Kari Wilder-Romans, Nicole H. Hirsh, Hannah M. Carter, Anna R. Michmerhuizen, Benjamin C. Chandler, Andrea M. Pesch
Supplemental Figures (8) and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66aea7f468b7f4de3d6c90ef69c65486
https://doi.org/10.1158/2767-9764.22545201
https://doi.org/10.1158/2767-9764.22545201
Autor:
Corey Speers, Reshma Jagsi, Lori J. Pierce, Shyam Nyati, Meilan Liu, Cassandra L. Ritter, Nicole Hirsh, Amanda Zhang, Dafydd G. Thomas, Eric Olsen, Meleah Cameron, Kari Wilder-Romans, Benjamin C. Chandler, Leah Moubadder, Andrea M. Pesch, Anna R. Michmerhuizen
Higher doses of olaparib are sufficient to inhibit PAR formation in BRCA1-mutant SUM-149 cells. At higher concentrations of olaparib (1μM), combination treatment of PARP1 inhibition and radiation decreases PAR in a comparable manner to lower doses o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::623d55d5dd22fc6feaa49169a3f1f0b6
https://doi.org/10.1158/1535-7163.22518895
https://doi.org/10.1158/1535-7163.22518895
Autor:
Corey Speers, Reshma Jagsi, Lori J. Pierce, Shyam Nyati, Meilan Liu, Cassandra L. Ritter, Nicole Hirsh, Amanda Zhang, Dafydd G. Thomas, Eric Olsen, Meleah Cameron, Kari Wilder-Romans, Benjamin C. Chandler, Leah Moubadder, Andrea M. Pesch, Anna R. Michmerhuizen
Extended methods for immunohistochemistry. Antibodies used in immunohistochemistry experiments are listed with each of the corresponding dilutions, retrieval techniques, and positive controls.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dec1ab52d25aad68186ffb5ea9a1a23
https://doi.org/10.1158/1535-7163.22518883
https://doi.org/10.1158/1535-7163.22518883
Autor:
Corey Speers, Reshma Jagsi, Lori J. Pierce, Shyam Nyati, Meilan Liu, Cassandra L. Ritter, Nicole Hirsh, Amanda Zhang, Dafydd G. Thomas, Eric Olsen, Meleah Cameron, Kari Wilder-Romans, Benjamin C. Chandler, Leah Moubadder, Andrea M. Pesch, Anna R. Michmerhuizen
Sustained locoregional control of disease is a significant issue in patients with inflammatory breast cancer (IBC), with local control rates of 80% or less at 5 years. Given the unsatisfactory outcomes for these patients, there is a clear need for in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ab813eb94ed0666f01ed7b66b76c82
https://doi.org/10.1158/1535-7163.c.6542167
https://doi.org/10.1158/1535-7163.c.6542167